| 查看: 15136 | 回复: 410 | ||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | ||
[资源]
阿斯利康、葛兰素史克、诺华、辉瑞四家公司大牛做临床前安全性评价经验
|
||
|
Abstract In vitro pharmacological profiling is increasingly being used earlier in the drug discovery process to identify undesirable off-target activity profiles that could hinder or halt the development of candidate drugs or even lead to market withdrawal if discovered after a drug is approved. Here, for the first time, the rationale, strategies and methodologies for in vitro pharmacological profiling at four major pharmaceutical companies (AstraZeneca, GlaxoSmithKline, Novartis and Pfizer) are presented and illustrated with examples of their impact on the drug discovery process. We hope that this will enable other companies and academic institutions to benefit from this knowledge and consider joining us in our collaborative knowledge sharing. |
回复此楼» 本帖附件资源列表
-
欢迎监督和反馈：小木虫仅提供交流平台，不对该内容负责。
本内容由用户自主发布，如果其内容涉及到知识产权问题，其责任在于用户本人，如对版权有异议，请联系邮箱：xiaomuchong@tal.com - 附件 1 : nrd3845.pdf
2012-12-05 21:36:54, 567.19 K
» 本帖已获得的红花（最新10朵）
torlocy» 猜你喜欢
药物学论文润色/翻译怎么收费?
已经有263人回复
142楼2013-03-22 11:42:03
2楼2012-12-05 22:24:56
10楼2012-12-06 12:26:47
简单回复
but08083楼
2012-12-06 00:29
回复
五星好评 顶一下，感谢分享！
2012-12-06 08:36
回复
五星好评 顶一下，感谢分享！
bronya6楼
2012-12-06 08:59
回复
五星好评 顶一下，感谢分享！
2012-12-06 10:14
回复
五星好评 顶一下，感谢分享！
wangjubo8楼
2012-12-06 11:13
回复
五星好评 顶一下，感谢分享！
News9楼
2012-12-06 11:36
回复
五星好评 顶一下，感谢分享！
lics1987021011楼
2012-12-06 13:09
回复
五星好评 顶一下，感谢分享！
whui12楼
2012-12-06 13:10
回复
五星好评 顶一下，感谢分享！
ciren112913楼
2012-12-06 13:44
回复
五星好评 顶一下，感谢分享！
daixc82023914楼
2012-12-06 14:44
回复
五星好评 顶一下，感谢分享！